KR100587423B1 - 알로에 펙틴 - Google Patents

알로에 펙틴 Download PDF

Info

Publication number
KR100587423B1
KR100587423B1 KR1020007012701A KR20007012701A KR100587423B1 KR 100587423 B1 KR100587423 B1 KR 100587423B1 KR 1020007012701 A KR1020007012701 A KR 1020007012701A KR 20007012701 A KR20007012701 A KR 20007012701A KR 100587423 B1 KR100587423 B1 KR 100587423B1
Authority
KR
South Korea
Prior art keywords
pectin
aloe
aloe pectin
extraction
abandoned
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020007012701A
Other languages
English (en)
Korean (ko)
Other versions
KR20010052346A (ko
Inventor
니야웨이
예이츠케네스엠
자르직키리스자드
Original Assignee
캐링턴 라보라토리즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 캐링턴 라보라토리즈, 인코포레이티드 filed Critical 캐링턴 라보라토리즈, 인코포레이티드
Publication of KR20010052346A publication Critical patent/KR20010052346A/ko
Application granted granted Critical
Publication of KR100587423B1 publication Critical patent/KR100587423B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • C08B37/0048—Processes of extraction from organic materials
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/06—Pectin; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/06—Pectin; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Sustainable Development (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
KR1020007012701A 1998-05-13 1999-05-12 알로에 펙틴 Expired - Fee Related KR100587423B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9/078,204 1998-05-13
US09/078,204 1998-05-13
US09/078,204 US5929051A (en) 1998-05-13 1998-05-13 Aloe pectins

Publications (2)

Publication Number Publication Date
KR20010052346A KR20010052346A (ko) 2001-06-25
KR100587423B1 true KR100587423B1 (ko) 2006-06-08

Family

ID=22142598

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007012701A Expired - Fee Related KR100587423B1 (ko) 1998-05-13 1999-05-12 알로에 펙틴

Country Status (8)

Country Link
US (1) US5929051A (enExample)
EP (2) EP1607407A3 (enExample)
JP (1) JP2002514663A (enExample)
KR (1) KR100587423B1 (enExample)
AU (1) AU3898999A (enExample)
CA (1) CA2331744C (enExample)
DE (1) DE69927498T2 (enExample)
WO (1) WO1999058575A1 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313103B1 (en) * 1998-05-13 2001-11-06 Carrington Laboratories, Inc. Pectic substance as a growth factor stabilizer
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US6916495B2 (en) * 1999-02-24 2005-07-12 Allan Taylor Preparation for regulating lower bowel function
AU2001227921A1 (en) * 2000-01-19 2001-07-31 University Of Pittsburgh Improvements to artificial blood fluids and microflow drag reducing factors for enhanced blood circulation
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
DE60222106T2 (de) * 2001-04-10 2007-12-27 Basf Ag Mikrokapseln
WO2005095463A1 (en) 2004-03-26 2005-10-13 Glycogenesys, Inc. Modified pectins, compositions and methods related thereto
AR048709A1 (es) * 2004-04-26 2006-05-17 Cp Kelco Aps Composicion dermoprotectora para controlar la alcalinidad y uso de la misma
EP1883396B1 (en) * 2005-05-18 2013-07-03 DA Volterra Colonic delivery of adsorbents
US20070098870A1 (en) * 2005-10-27 2007-05-03 Trudsoe Jens E Composition containing alkylene oxide derivative of pectin
RU2356572C1 (ru) * 2005-11-25 2009-05-27 Моринага Милк Индастри Ко., Лтд. Экстракт алоэ вера, метод получения экстракта алоэ вера и снижающий гипергликемию агент
EP1986617A2 (en) * 2006-02-20 2008-11-05 Aristide Maffei Extraction, preparation and use of active principles of the aloe plant to realize of self-medication devices such as aloe controlled-release gauzes, bandages, stockings, elastic bands and arch supports
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
US7850382B2 (en) 2007-01-18 2010-12-14 Sanford, L.P. Valve made from two materials and writing utensil with retractable tip incorporating same
US7488130B2 (en) 2007-02-01 2009-02-10 Sanford, L.P. Seal assembly for retractable instrument
WO2008140820A2 (en) * 2007-05-11 2008-11-20 Aloebiotics Research Labs, Inc. Aloe preparation for skin enhancement
WO2009051622A2 (en) * 2007-10-12 2009-04-23 Immuneregen Biosciences, Inc. Methods for stimulating fibroblast proliferation using substance p analogs
US8226312B2 (en) 2008-03-28 2012-07-24 Sanford, L.P. Valve door having a force directing component and retractable instruments comprising same
US7833829B2 (en) * 2008-10-28 2010-11-16 Honeywell International Inc. MEMS devices and methods of assembling micro electromechanical systems (MEMS)
US8221012B2 (en) 2008-11-07 2012-07-17 Sanford, L.P. Retractable instruments comprising a one-piece valve door actuating assembly
JP4761584B2 (ja) * 2008-11-07 2011-08-31 長谷川香料株式会社 粘性物質の除去されたアロエ葉肉加工品の製造方法
US8393814B2 (en) 2009-01-30 2013-03-12 Sanford, L.P. Retractable instrument having a two stage protraction/retraction sequence
WO2011079260A2 (en) * 2009-12-23 2011-06-30 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Stabilized virus like particles having enhanced mucosal immunogenicity
WO2011096122A1 (ja) * 2010-02-03 2011-08-11 森永乳業株式会社 アロエパウダーの製造方法
EP2468110A1 (en) * 2010-12-22 2012-06-27 Nestec S.A. Gel composition comprising low-methoxy pectin
WO2013101314A1 (en) * 2011-12-28 2013-07-04 Galectin Therapeutics, Inc. Composition of novel carbohydrate drug for treatment of human diseases
ES2848538T3 (es) * 2012-06-06 2021-08-10 Galectin Therapeutics Inc Composiciones de galacto-ramnogalacturonato para el tratamiento de enfermedades asociadas con elevada óxido nítrico sintasa inducible
CN103113482A (zh) * 2012-12-19 2013-05-22 盐城工学院 一种超临界co2法萃取大米草多糖的工艺
US9750672B1 (en) * 2013-01-28 2017-09-05 AL Global Inc. Aloe derived mineral supplement
CN103204953A (zh) * 2013-03-22 2013-07-17 安徽亿源生物工程有限公司 一种超临界流体co2提取薯渣中果胶的方法
CN103739725B (zh) * 2013-10-11 2016-05-11 云南万绿生物股份有限公司 高含量高纯度芦荟多糖的精制方法
CN104650258A (zh) * 2013-11-21 2015-05-27 张名静 一种低脂果胶提取方法
JP2017514961A (ja) * 2014-05-08 2017-06-08 ナノセラピューティクス・インコーポレイテッドＮａｎｏｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． Ｏ−アセチル化高分子ポリガラクツロン酸およびＶｉ多糖類ワクチンとしてのその利用
CN104086669A (zh) * 2014-06-30 2014-10-08 石河子大学 一种盐法提取甜菜果胶的方法
CN105175577A (zh) * 2015-09-24 2015-12-23 吴莹 食用级芦荟果胶的提取工艺
WO2018208632A1 (en) 2017-05-12 2018-11-15 Corning Incorporated A cross-linked shear thinning fluid with tunable rheology for 3d bioprinting and drug delivery
US20190230960A1 (en) * 2017-10-18 2019-08-01 Glanbia Nutritionals (Ireland) Ltd. Shelf-Stable Nitrogenous Organic Acid Compositions
US20220053795A1 (en) * 2017-10-18 2022-02-24 Gaurav Parekh Method for Increasing the Solubility and Stability of Organic Compositions
CN108314748A (zh) * 2018-03-23 2018-07-24 仲恺农业工程学院 一种芦荟皮果胶提取工艺
PL3774927T3 (pl) * 2018-03-26 2024-07-29 Cp Kelco Aps Pektyna charakteryzująca się niskim stopniem estryfikacji metylem i wysoką lepkością istotną
EP3820983A1 (en) * 2018-07-09 2021-05-19 Coöperatie Koninklijke Cosun U.A. Antiscalant composition comprising a uronic acid polysaccharide
EP4188116A1 (de) 2020-08-03 2023-06-07 Herbstreith & Fox GmbH & Co. KG Pektin-Fabriken Calciumpektinat

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959214A (en) * 1985-06-28 1990-09-25 Carrington Laboratories Inc. Processes for preparation of aloe products products produced thereby and compositions thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3622559A (en) * 1967-11-01 1971-11-23 Sunkist Growers Inc Method for producing pectins having high resistance to breakage and high capability for gelling in the presence of calcium
US4016351A (en) * 1976-02-04 1977-04-05 Eschinasi Emile H Pectic substances with varying methoxyl content and process therefor
US4497838A (en) * 1982-02-17 1985-02-05 Tropicana Products, Inc. Process for the production of useful products from orange peel
US5656587A (en) * 1982-09-24 1997-08-12 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Promotion of cell proliferation by use of transforming growth factor beta (TGF-β)
JPS60108402A (ja) * 1983-11-16 1985-06-13 Hikaru Konishi 植物性原料からペクチンの効率的製造方法
US5552528A (en) * 1986-03-03 1996-09-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bovine b-endothelial cell growth factor
JPS62255415A (ja) * 1986-04-28 1987-11-07 Soda Koryo Kk アロエ透明外用剤の製造法
FR2613936B1 (fr) * 1987-04-17 1990-03-30 Centre Nat Rech Scient Application des resines constituees par des polymeres fonctionnels comme phase stationnaire en chromatographie d'affinite pour la purification des facteurs de croissance et procede de purification correspondant
JPS6465101A (en) * 1987-09-05 1989-03-10 Takeshi Ishii Water hyacinth pectin
EP0555205B1 (en) * 1989-01-31 2000-11-29 RUBIN, Jeffrey S Dna encoding a growth factor specific for epithelial cells
US5356630A (en) * 1989-02-22 1994-10-18 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
US5576288A (en) * 1989-04-27 1996-11-19 The Salk Institute For Biological Studies Fibroblast growth factor conjugates
US5191067A (en) * 1989-04-27 1993-03-02 The Salk Institute For Biological Studies Fibroblast growth factor conjugates
US5130418A (en) * 1989-05-02 1992-07-14 California Biotechnology Inc. Method to stabilize basic fibroblast growth factor
JPH0330831A (ja) * 1989-06-27 1991-02-08 Lion Corp マイクロカプセル
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
US5217954A (en) * 1990-04-04 1993-06-08 Scios Nova Inc. Formulations for stabilizing fibroblast growth factor
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
US5714458A (en) * 1990-07-18 1998-02-03 Farmitalia Carlo Erba S.R.L. Stable pharmaceutical compositions containing a fibroblast growth factor
EP0486862B1 (en) * 1990-11-23 1996-05-29 American Cyanamid Company Chimeric fibroblast growth factor
HU220375B (hu) * 1991-11-14 2002-01-28 Dsm N.V. Eljárás ivólevek és pektintartalmú törköly, és az utóbbiból pektin előállítására, és az így kapott termékek
DE4201172C1 (en) * 1992-01-17 1993-07-22 Alfatec-Pharma Gmbh, 6900 Heidelberg, De Pellets contg. Aloe vera extract - useful, e.g. as antiinflammatory of antibiotic agents, or for treating gastric ulcers
US5514652A (en) * 1992-02-14 1996-05-07 Kaken Pharmaceutical Co., Ltd. Therapy of respiratory tract diseases using basic fibroblast growth factor
US5703047A (en) * 1992-09-21 1997-12-30 Board Of Regents, The University Of Texas System Methods and treatments for corneal healing with growth factors
US5589451A (en) * 1992-09-21 1996-12-31 Board Of Regents, The University Of Texas System Methods and treaments for corneal healing with hepatocyte and keratinocyte growth factors
US5453492A (en) * 1993-07-28 1995-09-26 La Jolla Cancer Research Foundation 60 kDa transforming growth factor-β-binding protein and its use to detect or purify TGF-β
US5464815A (en) * 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
CA2184916C (en) * 1994-03-08 2008-05-13 Colin R. Dunstan Use of fibroblast growth factors to stimulate bone growth
US5656598A (en) * 1994-03-08 1997-08-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Use of fibroblast growth factors to stimulate bone growth
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent
US5693775A (en) * 1995-05-12 1997-12-02 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
US5656734A (en) * 1995-10-30 1997-08-12 Systems Bio-Industries Methods for making pectin and pectocellulosic products

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959214A (en) * 1985-06-28 1990-09-25 Carrington Laboratories Inc. Processes for preparation of aloe products products produced thereby and compositions thereof

Also Published As

Publication number Publication date
US5929051A (en) 1999-07-27
DE69927498T2 (de) 2006-07-13
WO1999058575A1 (en) 1999-11-18
AU3898999A (en) 1999-11-29
DE69927498D1 (de) 2006-02-09
EP1086141B1 (en) 2005-09-28
KR20010052346A (ko) 2001-06-25
JP2002514663A (ja) 2002-05-21
CA2331744C (en) 2010-10-05
EP1607407A3 (en) 2006-05-24
CA2331744A1 (en) 1999-11-18
EP1607407A2 (en) 2005-12-21
EP1086141A1 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
KR100587423B1 (ko) 알로에 펙틴
US7022683B1 (en) Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
Cho et al. Green process development for apple-peel pectin production by organic acid extraction
Pan et al. Physicochemical and structural properties of three pectin fractions from muskmelon (Cucumis melo) and their correlation with juice cloud stability
Goycoolea et al. Pectins from Opuntia spp.: A short review
Coimbra et al. Isolation and characterisation of cell wall polymers from olive pulp (Olea europaea L.)
Donati et al. Material properties of alginates
Srivastava et al. Sources of pectin, extraction and its applications in pharmaceutical industry-An overview
Novosel'Skaya et al. Trends in the science and applications of pectins
Sengkhamparn et al. Characterisation of cell wall polysaccharides from okra (Abelmoschus esculentus (L.) Moench)
Sriamornsak Chemistry of pectin and its pharmaceutical uses: A review
Méndez et al. Tailoring structural, rheological and gelling properties of watermelon rind pectin by enzymatic treatments
Feng et al. Physicochemical and rheological characterization of pectin-rich fraction from blueberry (Vaccinium ashei) wine pomace
Günter et al. Characterization and swelling properties of composite gel microparticles based on the pectin and κ-carrageenan
Ammar et al. Influence of the uronic acid composition on the gastroprotective activity of alginates from three different genus of Tunisian brown algae
Stephen et al. Gums and mucilages
JP2021500085A (ja) 感染症の治療又は予防のためのペクチン性多糖酵素加水分解物
Naseri et al. Citrus pectin: Structure and application in acid dairy drinks
Reitsma et al. Properties of amidated pectins. I. Preparation and characterization of amidated pectins and amidated pectic acids
Manthei et al. Ultrasonication and enzymatic treatment of apple and orange bagasses: Molecular characterization of released oligosaccharides and modification of techno-functional and health-related properties
Sartori The characterisation of alginate systems for biomedical applications
Wang et al. Cell wall polysaccharides from Annona squamosa: Chemical and functional characterization
Abbaszadeh Pectin and galacturonic acid from citrus wastes
Kravtchenko Studies on the structure of industrial high methoxyl pectins
Yu et al. Lycium barbarum leaf polysaccharide Pickering emulsion for curcumin delivery: Interactions between curcumin and polysaccharides at the oil-water interface

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20090531

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20090531

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000